Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Jubilant Life Sciences Ltd - 530019 - Board recommends Dividend

 Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 17, 2019, inter alia, has recommended a dividend of Rs. 4.50 (Four Rupees and Fifty Paisa only) per equity share of Re. 1 each for the year ended March 31, 2019. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before October 24, 2019.
17-05-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Outcome of Board Meeting

 Dear Sirs, Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. on May 17, 2019, recommended a dividend of Rs. 4.50 (Four Rupees and Fifty Paisa only) per equity share of Re.1 each for the year ended March 31, 2019. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid / despatched on or before October 24, 2019. We request you to take the same on record.
17-05-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Financial Results For The Quarter And Year Ended March 31, 2019

 Dear Sirs, In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2019 were approved by the Board of the Company at its meeting held today at 2.00 p.m. and concluded at 3.50 p.m. Pursuant to the applicable provisions of the Listing Regulations, we enclose the following: 1. The Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2019; 2. Audit Reports for Standalone and Consolidated Financial Results; 3. Copies of the Press Release and Presentation. We declare that the Reports of Auditors are with unmodified opinion with respect to the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2019.
17-05-2019
Bigul

Annual report for Jubilant Life Sciences Ltd. for FY-2019
17-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Reg.: Intimation of loss of share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that share certificate has been reported to be lost by the shareholder as per the attached document. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
13-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Sub.: Submission of copies of newspaper advertisements In continuation of our letter dated May 9, 2019, we enclose copies of the advertisements published on May 10, 2019, in MINT (English) and HINDUSTAN (Hindi) with respect to notice of the Board Meeting scheduled to be held on May 17, 2019. This is for information and record.
10-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Reg.: Intimation of loss of share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that share certificate has been reported to be lost by the shareholder as stated in the attached documents. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
10-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Sub.: Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Audited Financial Results For The Year Ended March 31, 2019

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on May 17, 2019 after submission of the financial results for the quarter and year ended March 31, 2019 to the Stock Exchanges. The details of Conference Call are attached. This is for information and record.
09-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Board to consider FY19 results & Dividend on May 17, 2019

 Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 17, 2019, inter alia, to consider:1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2019;2. Recommendation of Dividend for the Financial Year ended March 31, 2019.
09-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Board Meeting Intimation for Sub: Intimation Of Board Meeting - May 17, 2019

 JUBILANT LIFE SCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2019 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 17, 2019, to inter-alia consider: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2019; 2. Recommendation of Dividend for the Financial Year ended March 31, 2019. This is for information and record.
09-05-2019
Next Page
Close

Let's Open Free Demat Account